Αποτελέσματα Αναζήτησης
30 Ιουλ 2017 · Screening for HIV in primary care is cost-effective in the medium term in settings of high HIV incidence such as Hackney because of lower health-care costs of people living with HIV if diagnosed earlier and ongoing reductions in HIV transmission.
17 Μαρ 2020 · Results: Compared to no baseline genotype, baseline genotype resulted in <1 additional undiscounted quality-adjusted life-day (QALD), cost an additional $500/person, and was not cost-effective (incremental cost-effectiveness ratio: $420 000/quality-adjusted life-year).
12 Μαρ 2021 · In The Lancet Global Health, Ranjeeta Thomas and colleagues 3 report on a cost-effectiveness analysis model, projecting that combination HIV prevention including UTT (ie, PopART) is cost-effective at thresholds greater than US$800 per disability-adjusted life year (DALY) averted in individuals older than 14 years.
Detect resistance of HIV-1 to protease, reverse transcriptase, and integrase inhibitors. This procedure may not be successful when the HIV viral load is <500 copies/mL plasma.
10 Φεβ 2005 · Screening cost less than $50,000 per quality-adjusted life-year if the prevalence of unidentified HIV infection exceeded 0.05 percent. Excluding HIV transmission, the cost-effectiveness of...
9 Φεβ 2024 · If you get a diagnosis of HIV/AIDS, tests can help your healthcare professional learn the stage of your disease and the best treatment, including: CD4 T cell count. CD4 T cells are white blood cells that HIV targets and destroys.
Under most assumptions, PI monotherapy appears to be a cost-effective treatment strategy compared with OT for HIV-infected patients who have achieved sustained virological suppression.
